Browse studies, page 424
Page 424 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Prescribing trends of fixed-dose combination of domperidone and proton-pump inhibitor across tertiary care centers in India, is the combination rational? Indian journal of pharmacology, 2025
- VCTE Overestimates Liver Fibrosis due to Abdominal-Truncal Adiposity and Not Hepatic Steatosis: A Case Report Case reports in gastrointestinal medicine, 2024
- Greenness-sustainability metrics for assessment smart-chemometric spectrophotometric strategy for evaluation of the combination of six gastric proton-pump inhibitors with two selected impurities MethodsX, 2024
- Proton pump inhibitors-induced thrombocytopenia: A systematic literature analysis of case reports Open medicine (Warsaw, Poland), 2025
- Eosinophilic Esophagitis in the Middle East: Insight From a Comprehensive Systematic Review JGH open : an open access journal of gastroenterology and hepatology, 2026
- Utilization of Acid Suppressants After Withdrawal of Ranitidine in Korea: An Interrupted Time Series Analysis Journal of preventive medicine and public health = Yebang Uihakhoe chi, 2025
- A Lifelong Battle With Crouzon Syndrome: A Detailed Case Report of Extensive Craniofacial Surgeries and Complex Psychiatric Care Cureus, 2025
- Update on the PriME-PGx initiative: evolution of pharmacogenetics in daily clinical practice Pharmacogenomics, 2024
- Deprescribing of proton pump inhibitors in internal medicine in-patients: A retrospective observational study Exploratory research in clinical and social pharmacy, 2026
- Association between exposure to proton pump inhibitors and delirium: a descriptive and disproportionality analysis of VigiBase BMJ open, 2024
- Gastroesophageal reflux disease and temporomandibular disorder risk: a nationwide cohort study BMC oral health, 2026
- The Death of the Strategy of Classical Chiral Switches Is an Exaggeration ACS medicinal chemistry letters, 2024
- Antiplatelet-Proton Pump Inhibitor Interactions and Arterial Thrombotic Events: A Pharmacovigilance Assessment using Disproportionality and Interaction Analysis Current cardiology reviews, 2025
- Association of Proton Pump Inhibitor Use with Cancer in Patients Undergoing Maintenance Hemodialysis: A Population-Based Cohort Study Journal of clinical medicine, 2026
- Computational drug-drug interaction prediction mediated by CYP450 isoforms of Ilaprazole coadministered with clopidogrel Future science OA, 2024
- Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease The Cochrane database of systematic reviews, 2025
- Proton pump inhibitors are associated with increased risk of pseudoarthrosis after lumbar fusion North American Spine Society journal, 2026
- CYP2C19 variability and clinical outcomes of clopidogrel, proton pump inhibitors, and voriconazole in Southeast Asia: a systematic review and meta-analysis Frontiers in pharmacology, 2025
- The effect of the use of proton pump inhibitors (PPI) on complications in patients with cirrhosis BMC gastroenterology, 2026
- Proton pump inhibitor use and risk of dementia in a population-based cohort study Scientific reports, 2026
- The Effect of Tegoprazan on Serum Gastrin Levels and the Development of Hypergastrinemia in the Maintenance Treatment for Gastroesophageal Reflux Disease: Comparison to Lansoprazole Journal of neurogastroenterology and motility, 2025
- Proton pump inhibitors use and the risk of osteoporosis and fractures: A two-sample Mendelian randomization study Medicine, 2026
- Clostridioides difficile Infection in Patients Undergoing Acid-Suppressive Treatment: A Large Cohort Study with Propensity Score Matching Digestive diseases (Basel, Switzerland), 2025
- Palmoplantar plaque psoriasis responsive to upadacitinib: A report of two cases SAGE open medical case reports, 2025
- Drug Administration via Enteral Feeding Tubes: A Landscape Analysis of Information in Drug Product Labeling Journal of clinical pharmacology, 2026
- Does the use of proton pump inhibitors lead to an increased risk of dental implant failure? A systematic review and meta-analysis Medicina oral, patologia oral y cirugia bucal, 2025
- Self-Reported Pharmacogenetic Medication Use in the Our Future Health Cohort Clinical and translational science, 2026
- Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions Pharmaceuticals (Basel, Switzerland), 2025
- Exploring the Anticancer Potential of Proton Pump Inhibitors by Targeting GRP78 and V-ATPase: Molecular Docking, Molecular Dynamics, PCA, and MM-GBSA Calculations International journal of molecular sciences, 2025
- Ayurvedic management of Irritable Bowel Syndrome (Grahani Roga): A case report Journal of Ayurveda and integrative medicine, 2026
- Severe Coronary Vasospasm and the Role of Nontraditional Risk Factors JACC. Case reports, 2026
- Proton Pump Inhibitors in Pediatric Gastroesophageal Reflux Disease: A Systematic Review of Randomized Controlled Trials Children (Basel, Switzerland), 2024
- Omeprazole and Risk of Hypertension: Analysis of Existing Literature and the WHO Global Pharmacovigilance Database Drugs - real world outcomes, 2024
- Disproportionality Analysis of Renal Adverse Events Associated with a Combination of Immune Checkpoint Inhibitors and Acid-Suppressing Agents-A Pharmacovigilance Study Based on the FAERS Database Journal of clinical medicine, 2025
- A Swiss Cross-Sectional Study on Patients' Perspectives on Chronic Pain Management, Analgesic Treatment, and Genetic Susceptibility Journal of pain research, 2025
- Drug treatment strategies for erosive esophagitis in adults: a narrative review Translational gastroenterology and hepatology, 2025
- P‐ CAB vs. PPI for Upper Gastrointestinal Bleeding Prevention in Patients With Atherothrombotic Disease on Antithrombotic Therapy: A CDM Cohort Study Alimentary pharmacology & therapeutics, 2026
- Clinical Outcomes of Tegoprazan Versus Proton Pump Inhibitors in Patients Receiving Antiplatelet Therapy After Percutaneous Coronary Intervention: A Retrospective, Observational Study The Korean journal of helicobacter and upper gastrointestinal research, 2026
- Proton pump inhibitor exposure modulates functional and transcriptional responses in Lactobacillus acidophilus: a comprehensive computational and experimental insights Frontiers in cellular and infection microbiology, 2026
- Design and implementation of PharMe: a mobile application to return pharmacogenomic test results to patients JAMIA open, 2026
- Effect of tegoprazan on temporal variability of platelet reactivity in patients treated with clopidogrel after coronary stenting The Korean journal of internal medicine, 2025
- Safety and efficacy of tegoprazan in patients treated with dual antiplatelet therapy after coronary stenting for acute myocardial infarction Scientific reports, 2026
- CYP2C19 c. 681G >A Is not in Complete Linkage Disequilibrium With c.332‐ 23A >G: Implications for Pharmacogenetic Testing Clinical and translational science, 2026
- Impact of CYP2C19 and CYP3A4 Inhibitor Use on Clopidogrel Clinical Effectiveness in CYP2C19 Genotyped Patients Undergoing Percutaneous Coronary Intervention Clinical pharmacology and therapeutics, 2026
- Genetic Landscape of VIP Pharmacogenomic Variants in the Kinh Vietnamese Population Pharmacogenomics and personalized medicine, 2025
- Availability and Pricing of Drugs Prescribed by Otolaryngologists Through a Direct-to-Consumer Pharmacy: Medicare Savings Implications Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2025
- Association Between Proton Pump Inhibitor Use and Malnutrition Risk in the US General Population Using the GLIM Framework (NHANES 1999-2020) Pharmacoepidemiology and drug safety, 2026
- Pharmacogenomic Calling From Whole-Exome Sequencing in the Taiwanese Population-A Real-World Experience Molecular genetics & genomic medicine, 2026
- Proton pump inhibitors use and risk of type 2 diabetes mellitus: correlation analysis, prediction model construction, and key genes identification Frontiers in pharmacology, 2025
- Delineating CYP2C19-mediated Interactions: Network Pharmacology Investigation of Ilaprazole and Clopidogrel versus Conventional Proton Pump Inhibitors Current drug discovery technologies, 2025
- Comparative Efficacy and Safety of Tegoprazan Versus Proton Pump Inhibitors for Erosive Esophagitis: A Systematic Review and Meta-Analysis Cureus, 2025
- Differential fracture risk among proton pump inhibitors in older adults: evidence network and pharmacovigilance validation Frontiers in pharmacology, 2026
- Pharmacodynamics, pharmacokinetics, interactions with other drugs, toxicity and clinical effectiveness of proton pump inhibitors Frontiers in pharmacology, 2025
- Immediate-Type PPI Hypersensitivity as a Severe Adverse Drug Reaction: Diagnostic Challenges, Cross-Reactivity, and Real-Life Outcomes Journal of clinical medicine, 2026
- Cancer related adverse events associated with use of proton pump inhibitors and histamine-2 receptor antagonists: A real-world analysis using the FDA adverse event reporting system PloS one, 2025
- Self-reported pharmacogenetic medication use in the Our Future Health cohort 2025
- Vitamin B12 Deficiency Associated with Metformin and Proton Pump Inhibitors and Their Combinations: Results from a Disproportionality and Interaction Analysis Diseases (Basel, Switzerland), 2025
- Risk of Depression Related to Use of Proton Pump Inhibitors and Tegoprazan: A Nationwide Cohort Study Journal of Korean medical science, 2026
- Assessing the Frequency, Prescribing Patterns, and Characteristics of Patients Receiving Drugs with Pharmacogenomic (PGx) Guidelines Through an EMR: Follow-Up Analysis 5 Years Later Pharmacy (Basel, Switzerland), 2026
- Incidence of Barrett's esophagus and esophageal cancer following sleeve gastrectomy versus liraglutide therapy Annals of gastroenterology, 2026
- Lifestyle Intervention in Post-infectious GERD With Respiratory and Esophageal Manifestations: A Case Report American journal of lifestyle medicine, 2025
- So Many Choices, So Little Value: Potential Savings from Selecting Cost-Effective Proton Pump Inhibitors PharmacoEconomics - open, 2025
- Systematic analysis of proton pump inhibitors-related adverse reactions using the FDA adverse event reporting system database PloS one, 2026
- Safety of Proton Pump Inhibitor in Paediatrics: A Study Based on EudraVigilance Data Fundamental & clinical pharmacology, 2025
- FAERS-based pharmacovigilance and network toxicology analysis of esomeprazole-associated osteoporosis PloS one, 2026
- Association between exposure to proton pump inhibitors and hypertension: a descriptive and disproportionality analysis of VigiBase BMJ open, 2025
- Data mining results for reduction of adverse drug-drug interaction events in older adults are clinically applicable Therapeutic advances in drug safety, 2025
- Causal Effects of Plasma Metabolites on Intervertebral Disc Degeneration and Low Back Pain: A Mendelian Randomization Study Metabolites, 2026
- Proton Pump Inhibitors and Risk of Chronic Kidney Disease: A Systematic Review and Meta-Analysis Cureus, 2026
- A Vanished Association Between Proton Pump Inhibitors and Clostridioides Difficile Infection After Minimizing Bias Journal of clinical medicine, 2025
- Patients' perception of proton pump inhibitors use and their risks World journal of clinical oncology, 2026
- Probable Serotonin Syndrome Precipitated by the Addition of Trazodone to Lurasidone and Valproic Acid: A Case Report Sante mentale au Quebec, 2026
- Tegoprazan in Gastroesophageal Reflux Disease and Related Acid-Mediated Conditions: A Systematic Review and Meta-Analysis JGH open : an open access journal of gastroenterology and hepatology, 2026
- Beyond acid suppression: the multifaceted role of proton pump inhibitors in Helicobacter pylori eradication Frontiers in microbiology, 2026
- Reduction of Proton Pump Inhibitor Dependence in Gastroesophageal Reflux Disease Following Isometric Diaphragmatic Resistance Training With a Novel Respiratory Muscle Training Device: An Autobiographical Case Report Cureus, 2026
- Intranasal nanoemulsion-based in-situ gel containing dexlansoprazole: formulation development, in-vitro and ex-vivo evaluation Drug development and industrial pharmacy, 2026
- Sustained Remission Following Limited Dupilumab Exposure in Refractory Eosinophilic Esophagitis ACG case reports journal, 2026
- Protective effects of esomeprazole against cisplatin-induced ototoxicity: an in vitro and in vivo study Aquatic toxicology (Amsterdam, Netherlands), 2023
- Stereoselective inhibition of cytochrome P450 forms by lansoprazole and omeprazole in vitro Xenobiotica; the fate of foreign compounds in biological systems, 2005
- High and Frequent Dose of Dexlansoprazole and Amoxicillin Dual Therapy for Helicobacter pylori Infections: A Single Arm Prospective Study The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2017
- High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections Helicobacter, 2014
- Impact of Gastric H+/K+-ATPase rs2733743 on the Intragastric pH-Values of Dexlansoprazole Injection in Chinese Subjects Frontiers in pharmacology, 2017
- The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD. The American journal of gastroenterology, 2011
- Maintenance of heartburn relief after step-down from twice-daily proton pump inhibitor to once-daily dexlansoprazole modified release Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2012
- Clinical trial: the effect and timing of food on the pharmacokinetics and pharmacodynamics of dexlansoprazole MR, a novel Dual Delayed Release formulation of a proton pump inhibitor--evidence for dosing flexibility Alimentary pharmacology & therapeutics, 2009
- The FDA-approved drugs ticlopidine, sertaconazole, and dexlansoprazole can cause morphological changes in C. elegans Chemosphere, 2020
- Improving the solubility of dexlansoprazole by cocrystallization with isonicotinamide European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2016
- Targeting G3BP1-Mediated Stress Granules to Suppress SARS-CoV-2 Replication ACS infectious diseases, 2026
- Sarcopenia and chronic pain: Identification of shared genetic determinants and therapeutic implication Medicine, 2026
- Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies Clinical drug investigation, 2009
- Nocturnal acid breakthrough and esophageal acidification during treatment with dexlansoprazole as compared to omeprazole in patients with gastroesophageal reflux disease Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2022
- Distinguishing the impact of dexlansoprazole on heartburn vs. regurgitation in patients with gastro-oesophageal reflux disease Alimentary pharmacology & therapeutics, 2013
- Dexlansoprazole for Heartburn Relief in Adolescents with Symptomatic, Nonerosive Gastro-esophageal Reflux Disease Digestive diseases and sciences, 2017
- Quality by Design Formulation Approach for the Development of Orodispersible Tablets of Dexlansoprazole Drug design, development and therapy, 2025
- Chiral separation in the class of proton pump inhibitors by chromatographic and electromigration techniques: An overview Electrophoresis, 2021
- The association between the use of proton pump inhibitors and the risk of hypomagnesemia: a systematic review and meta-analysis PloS one, 2014
- New spectroscopic methods for determination of dexlansoprazole using mercurochrome Luminescence : the journal of biological and chemical luminescence, 2021
- Acid peptic disorder compass: An Indian expert consensus on comprehensive management World journal of gastrointestinal pharmacology and therapeutics, 2026
- Comparison of hepatotoxicity of tegoprazan, a novel potassium-competitive acid blocker, with proton pump inhibitors using real-world data: A nationwide cohort study Frontiers in medicine, 2022
- Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents Digestive diseases and sciences, 2019
